Stay updated on Aducanumab in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedUpdates the displayed site revision identifier from **v3.5.2** to **v3.5.3** on the page footer.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Naples, Italy (postal codes 80131 and 80138) to the study locations and removed Napoli, Italy (postal codes 80131 and 80138).SummaryDifference0.0%

- Check41 days agoChange DetectedAdded front-end revision v3.5.0 and removed revision v3.4.3; no changes to study content or user-facing information.SummaryDifference0.0%

- Check48 days agoChange DetectedNew revision entry v3.4.3 has been added. The previous revision entry v3.4.2 has been removed.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.